Sukumar Nagendran - Net Worth and Insider Trading
Sukumar Nagendran Net Worth
The estimated net worth of Sukumar Nagendran is at least $81,800 dollars as of 2024-04-27. Sukumar Nagendran is the President and Head of R&D of Taysha Gene Therapies Inc and owns about 34,226 shares of Taysha Gene Therapies Inc (TSHA) stock worth over $81,800. Sukumar Nagendran is also the Sr. VP & Chief Medical Officer of AveXis Inc and owns about 0 shares of AveXis Inc (AVXS) stock worth over $0. Details can be seen in Sukumar Nagendran's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Sukumar Nagendran has not made any transactions after 2023-05-16 and currently still holds the listed stock(s).
Transaction Summary of Sukumar Nagendran
Sukumar Nagendran Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sukumar Nagendran owns 5 companies in total, including Taysha Gene Therapies Inc (TSHA) , Solid Biosciences Inc (SLDB) , and Immunovant Inc (IMVTU) among others .
Click here to see the complete history of Sukumar Nagendran’s form 4 insider trades.
Insider Ownership Summary of Sukumar Nagendran
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSHA | Taysha Gene Therapies Inc | 2023-05-16 | director |
| SLDB | Solid Biosciences Inc | 2018-09-12 | director |
| IMVTU | Immunovant Inc | 2019-05-09 | director |
| AVXS | AveXis Inc | 2018-05-15 | Sr. VP & Chief Medical Officer |
| IMVT | Immunovant Inc | 2019-05-09 | director |
Sukumar Nagendran Latest Holdings Summary
Sukumar Nagendran currently owns a total of 2 stocks. Among these stocks, Sukumar Nagendran owns 34,226 shares of Taysha Gene Therapies Inc (TSHA) as of May 16, 2023, with a value of $81,800 and a weighting of 100%. Sukumar Nagendran also owns 0 shares of AveXis Inc (AVXS) as of March 1, 2018, with a value of $0 and a weighting of 0%.
Latest Holdings of Sukumar Nagendran
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSHA | Taysha Gene Therapies Inc | 2023-05-16 | 34,226 | 2.39 | 81,800 |
| AVXS | AveXis Inc | 2018-03-01 | 0 | 217.83 | 0 |
Holding Weightings of Sukumar Nagendran
Sukumar Nagendran Form 4 Trading Tracker
According to the SEC Form 4 filings, Sukumar Nagendran has made a total of 1 transactions in Taysha Gene Therapies Inc (TSHA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Taysha Gene Therapies Inc is the acquisition of 5,000 shares on May 16, 2023, which cost Sukumar Nagendran around $3,400.
According to the SEC Form 4 filings, Sukumar Nagendran has made a total of 0 transactions in AveXis Inc (AVXS) over the past 5 years. The most-recent trade in AveXis Inc is the sale of 1,780 shares on March 1, 2018, which brought Sukumar Nagendran around $224,618.
Insider Trading History of Sukumar Nagendran
- 1
Sukumar Nagendran Trading Performance
GuruFocus tracks the stock performance after each of Sukumar Nagendran's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sukumar Nagendran is 178.9%. GuruFocus also compares Sukumar Nagendran's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sukumar Nagendran within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sukumar Nagendran's insider trading performs compared to the benchmark.
Performance of Sukumar Nagendran
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.75 | 178.9 | 126.88 | |||
| Relative Return to S&P 500(%) | 3.46 | 171.74 | 117.19 |
Sukumar Nagendran Ownership Network
Ownership Network List of Sukumar Nagendran
Ownership Network Relation of Sukumar Nagendran
Sukumar Nagendran Owned Company Details
What does Taysha Gene Therapies Inc do?
Who are the key executives at Taysha Gene Therapies Inc?
Sukumar Nagendran is the director of Taysha Gene Therapies Inc. Other key executives at Taysha Gene Therapies Inc include director & 10 percent owner Paul B Manning , Chief Financial Officer Kamran Alam , and 10 percent owner Session R.a. Ii .
Taysha Gene Therapies Inc (TSHA) Insider Trades Summary
Over the past 18 months, Sukumar Nagendran made 1 insider transaction in Taysha Gene Therapies Inc (TSHA) with a net purchase of 5,000. Other recent insider transactions involving Taysha Gene Therapies Inc (TSHA) include a net purchase of 18,066,667 shares made by Paul B Manning , a net sale of 549,095 shares made by Session R.a. Ii , and a net purchase of 777,778 shares made by Stalfort John A Iii .
In summary, during the past 3 months, insiders sold 0 shares of Taysha Gene Therapies Inc (TSHA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 582,095 shares of Taysha Gene Therapies Inc (TSHA) were sold and 19,405,000 shares were bought by its insiders, resulting in a net purchase of 18,822,905 shares.
Taysha Gene Therapies Inc (TSHA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Taysha Gene Therapies Inc Insider Transactions
Sukumar Nagendran Mailing Address
Above is the net worth, insider trading, and ownership report for Sukumar Nagendran. You might contact Sukumar Nagendran via mailing address: C/o Avexis, Inc., 2275 Half Day Road, Suite 160, Bannockburn Il 60015.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
